Capital Investment Advisors’s Boston Scientific BSX Stock Holding History

Capital Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$708K	Sell	11,288 -167	-1%	-$13.4K	0.01%	414
2025 Q4	$1.09M	Sell	11,455 -17	-0.1%	-$1.67K	0.02%	330
2025 Q3	$1.12M	Sell	11,472 -309	-3%	-$32K	0.02%	318
2025 Q2	$1.27M	Sell	11,781 -735	-6%	-$74.4K	0.02%	297
2025 Q1	$1.26M	Buy	12,516 +9,617	+332%	+$968K	0.02%	288
2024 Q4	$259K	Buy	2,899 +315	+12%	+$27.7K	0.01%	557
2024 Q3	$217K	Buy	+2,584	New	+$204K	﹤0.01%	601
2019 Q4	–	Sell	-5,120	Closed	-$208K	–	519
2019 Q3	$208K	Buy	5,120 +100	+2%	+$4.24K	0.01%	464
2019 Q2	$216K	Buy	+5,020	New	+$193K	0.01%	448
2018 Q4	–	Sell	-5,420	Closed	-$209K	–	478
2018 Q3	$209K	Buy	+5,420	New	+$189K	0.01%	452

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Investment Advisors's BSX Position: Q1 2026 in Review

Capital Investment Advisors reduced its Boston Scientific (BSX) stake by 1.5% in Q1 2026, selling an estimated $13.4K and leaving 11,288 shares worth $708K. The position accounts for 0.01% of the portfolio, ranked #414.

Capital Investment Advisors first reported a position in BSX in Q3 2018 and has held it in 10 quarters since. The position peaked at $1.27M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Capital Investment Advisors held 11,288 shares of Boston Scientific worth $708K as of Q1 2026.
Capital Investment Advisors sold 167 Boston Scientific shares in Q1 2026, an estimated $13.4K.
Boston Scientific made up 0.01% of Capital Investment Advisors's portfolio in Q1 2026, its #414 holding.
Capital Investment Advisors first reported a position in Boston Scientific in Q3 2018 and has held it in 10 quarters since.
Capital Investment Advisors's Boston Scientific position peaked at $1.27M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.